To treat bone defects, tissue-engineering methods combine an appropriate scaffold with cells and osteogenic signals to stimulate bone repair. Mesenchymal stem cells (MSCs) derived from adult bone marrow are an ideal source of cells for tissue engineering, in particular for applications in skeletal and hard tissue repair. Core binding factor 1 (Cbfa1) is an essential transcription factor for osteoblast differentiation. However, the effects of Cbfa1 on MSCs in vitro and in vivo have not been well characterized. In this study, we found that MSCs modified genetically to express Cbfa1 promoted the healing of segmental defects of the radius in rabbits. First, osteogenic differentiation of MSCs transfected with an adenovirus encoding Cbfa1 was demonstrated. Expression of mRNA from a number of osteoblastic marker genes, including osteocalcin, osteopontin, and type I collagen, was detected. In addition, alkaline phosphatase activity and increased osteocalcin content were observed. The cells expressing the Cbfa1 gene were then combined with acellular bone extracellular matrix in a flow perfusion culture system. Finally, the cell-matrix constructs were implanted into radius defects in the rabbit model. After 12 weeks, radiographic, histological, and biomechanical analyses showed that MSCs modified with the Cbfa1 gene resulted in a significantly higher amount of newlyformed bone and rebuilding of the marrow cavity than control cell-matrix constructs. This study indicates that MSCs modified with the Cbfa1 gene can act as suitable seed cells for the regeneration of bone defects.
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1-3) They do not usually heal spontaneously. Therefore, a variety of approaches have been employed to improve the healing of bone defects. [4] [5] [6] Among them, autologous bone graft is considered to be the gold standard for bone implantation. 7) However, this procedure has limitations, which include restrictions in the amount of bone available to harvest and potential problems associated with the secondary wound. Allogenic bone graft is another alternative to autograft, but there is a risk of rejection and potential transmission of pathogens. Since the 1990s, researchers have concentrated their efforts on the investigation and exploitation of tissue-engineered bone. The development of regenerative tissue repair by stem cell-mediated gene therapy has shown that stem cell-based approaches are one of the most promising alternative strategies in tissue engineering. 8) In general, stem cells that have been cultured in vitro are seeded onto a native or synthetic extracellular matrix, which might be biocompatible and biodegradable, and the scaffold, together with the seeded cells, is implanted into the local area that requires repair. Adhesion, proliferation, and differentiation of the cells should then occur.
Mesenchymal stem cells (MSCs) are pluripotent cells that can be isolated from adult bone marrow and can be induced in vitro and in vivo to differentiate into a variety of mesenchymal tissues, including bone, cartilage, tendon, fat, bone marrow stroma, and muscle. 9) These cells contribute to ongoing tissue maintenance and regeneration after injury in adults, and can easily be obtained and expanded. Thus MSCs are ideal cellular vehicles for the transduction and expression of therapeutic genes. Due to these advantages, MSCs are used most commonly as seed cells in bone tissue engineering. Compared with periosteum-derived osteoblasts, bone marrow MSCs can be manipulated more easily, cause less injury, and have lower immunogenicity. Many groups have reported that bone marrow MSCs are well suited to act as seed cells for the regenerative repair of defects of limb bones, dental alveoli, and the skull. [10] [11] [12] Core binding factor 1 (Cbfa1), an osteoblast-specific transcription factor, can be detected in condensing mesenchymal cells only during embryogenesis and in osteoblasts and bone during adulthood. 13) Analysis of gene knockout mice has shown that Cbfa1 is the predominant transcriptional activator of osteoblast-associated genes, and that its expression is essential for osteoblast differentiation and bone formation. 14, 15) However, the effect of Cbfa1 on MSCs in vitro and in vivo has not been described clearly.
In this study, we transfected the Cbfa1 gene into MSCs using a recombinant adenovirus vector. The genetically-modified MSCs and an acellular bone extracellular matrix, which was prepared from the bones of inbred Banna minipigs, were combined and cultured in a flow perfusion culture system. The engineered bones were then grafted into radius defects in rabbits.
Materials and Methods
Construction of recombinant adenovirus pAd-Cbfa1. Full-length Cbfa1 cDNA was excised from plasmid pCMV-Osf2 (the kind gift of Dr. Patricia Ducy, Baylor College of Medicine, Houston, TX) by digestion with EcoRI, and inserted into the EcoRI site of vector pEGFP-N1 (BD Clontech, Palo Alto, CA). This construct was then digested with BglII and SalI, and the fragment that contained the Cbfa1 cDNA was subcloned into the corresponding sites within the multiple cloning region of shuttle plasmid pAdTrack-CMV (generously provided by Dr. Bert Vogelstein, Johns Hopkins Oncology Center and Howard Hughes Medical Institute, Baltimore, MD). The resulting construct was named pAdTrack-CMV-Cbfa1. Following the method described in He et al., 16) pAdTrack-CMV-Cbfa1 and the control pAdTrack-CMV plasmid were transformed into AdEasier-1 cells to yield the recombinant adenovirus plasmid pAdEasy-1/Cbfa1 and the control plasmid. Then the recombinant adenovirus pAd-Cbfa1, and the control, pAd-CMV, were packaged in HEK 293 cells. The titers of the viral stocks were estimated by counting GFP-expressing cells, because pAdTrack-CMV also encodes GFP under the control of a separate CMV promoter. 17) Isolation, culture, and viral infection of rabbit MSCs. MSCs were isolated from the femurs of 12-week-old Japanese white rabbits (1.5-2.0 kg; Animal Research Center, Third Military Medical University). After anesthesia, rabbit bone marrow was collected into a 10-ml syringe that contained 5,000 U of heparin. The marrow was resuspended in 0.84% NH 4 Cl solution. After 5 min, approximately 2:0 Â 10 6 marrow cells were plated on a 25 cm 2 plastic flask in Dulbecco's Modified Eagle's Medium (DMEM) that was supplemented with 10% fetal bovine serum (FBS), 2 mM L-glutamine, 100 U/ml penicillin, and 100 mg/ml of streptomycin. For expansion, the cells were cultured in the growth medium at 37 C in a humidified atmosphere of 5% CO 2 . The medium was replaced twice per week. After 10-14 d of primary culture, the cells reached confluence. They were passaged and replated at a dilution of 1:3. Cells at passages 3-6 were used in the studies described here. MSCs were plated in 6-well plates and allowed to grow to 90% confluence before infection (approximately 1 Â 10 5 cells/well). The cells were incubated with the viral supernatant at a multiplicity of infection (MOI) of 50 plaque-forming units (PFU) per cell. Productive infection was confirmed by observing GFP expression under a fluorescence microscope. Uninfected MSCs and MSCs that had been infected with pAd-CMV adenoviruses were used as controls. One day after infection, the medium was replaced with conditional medium, which consisted of DMEM that contained 10% FBS supplemented with 10 mmol/l dexamethasone, 0.1 mmol/l L-ascorbic acid 2-phosphate (Sigma-Aldrich, St. Louis, MO) and 10 mmol/l -glycerophosphate (Sigma-Aldrich).
Western blot analysis. Proteins were extracted from 7 d cultures postinfection and quantitated with a protein assay kit (Bio-Rad). Protein samples (30 mg) were fractionated by SDS-polyacrylamide gel electrophoresis and transferred to a nitrocellulose membrane. Then the membrane was probed with a goat anti-Cbfa1 polyclonal antibody (Santa Cruz Biotechnology, Santa Cruz, CA). The secondary antibody (horseradish peroxidase-conjugated anti-goat immunoglobulin, 1:2,000 dilution) was used. Each membrane was probed with anti--actin (Sigma) to ensure equal protein loading. The bands were visualized by the chemiluminescence detection method (Amersham Biosciences) according to the manufacturer's protocol.
RT-PCR analysis of osteoblast differentiation and gene expression. Total RNA was extracted from the MSCs 7 and 14 d after infection using a commercially available kit (RNeasy Mini Kit; Qiagen, Valencia, CA). First-strand cDNA was synthesized from 1 mg of total RNA using a Reverse Transcription System kit (Promega, Madison, WI). PCR was performed using 2 ml of cDNA, 20 pmol of each primer (synthesized by Sangon, Shanghai, China), 200 mM dNTPs, 1 mM MgCl 2 , and 1U of Taq polymerase in a 50-ml reaction volume that contained 1 Â Taq polymerase buffer using a ThermoHybaid PCR System (ThermoHybaid, Ashford, Middlesex, UK). The specific primer sets are outlined in Table 1 . -actin was used as the internal control. The PCR products were separated on an agarose gel (1%) that contained ethidium bromide (0.125 mg/ml), visualized on a GelDoc XR documentation system (Bio-Rad Laboratories, Inc., Hercules, CA), and analyzed with Quantity One 4.2.3 software (Bio-Rad). Each PCR reaction was performed in duplicate using the same total RNA.
Determination of ALP activity and osteocalcin content. Cells that had been cultured in 6-well tissue culture cluster dishes for various durations were harvested in 1 ml of 0.2% Nonidet P-40, and the cell suspension was disrupted by sonication. After centrifugation at 1; 500 g for 5 min, the activity of alkaline phosphatase (ALP) was measured biochemically, as described previously 18) using p-nitrophenyl phosphate as the substrate. The amount of p-nitrophenol released by the enzyme reaction was measured at 405 nm using a Model 3550 Microplate Reader (Bio-Rad). Samples from three wells were analyzed at each culture time. Osteocalcin that had been released into the medium was measured by radioimmunoassay using an osteocalcin RIA Kit (Dongya, Beijing, China), which includes a goat anti-mouse osteocalcin antibody, according to the manufacturer's instructions. The radioactivity of the deposit was measured using an LS-6500 Liquid Scintillation Counter (Beckman, Fullerton, CA). The experiment was repeated 3 times.
Preparation of cell-matrix constructs. Pieces of acellular bone extracellular matrix 1:2 cm Â 0:5 cm Â 0:5 cm in size were prepared from inbred Banna minipig bones. 19) Briefly, a block of bone from the upper humerus and tibia cancellous bone and rib was cut into 1:0 Â 1:5 cm portions, immersed in phosphate-buffered saline (PBS) for 72 h, and then in 0.05 M Tris-HCl (pH 7.4) that contained 1 mM acetyl-pepstain, 0.5 mM 4-(2-aminoethyl) benzenesulfonyl fluoride hydrochloride (AEBSF), 2 mg/ml aprotinin, and 100 mM leupeptin for 48 h. Subsequently, the bone fragments were immersed in 3% Triton X-100 for a further 72 h. After washing in distilled water for 12 h, they were incubated with a DNAse/RNAse solution for 12 h. Finally, the bone matrix was freeze dried in a vacuum for 24 h and sterilized with 0 -CTTCCTTAATGTCACGCACGATTTC Co-60 -rays. The basic parameters of the matrix were porosity of 75.8% and a mean pore size of 253 AE 106 mm. Our previous data showed that the acellular bone matrix can provide a scaffold with the appropriate structure and strength for graft, and can be an ideal bone scaffold material. 20) MSCs were cultured in osteogenic medium and combined with the matrix. Two days before seeding, the MSCs were transduced with pAd-Cbfa1. MSCs cultured in ordinary medium were used as a control.
Prior to seeding, the bone scaffolds were prewetted for 2 h in DMEM medium. The cells were detached and resuspended in the medium at a cellular density of 1:0 Â 10 7 /ml. The cell suspension was added slowly to the matrix by injection of 1 ml with a 26-gauge needle until the scaffold material was soaked completely in the suspension. The cell-matrix constructs were then placed in an incubator at 37 C for 4 h. Subsequently, the respective media were added and the constructs were incubated at 37 C in 5% CO 2 . After incubation for one day, the constructs were transferred to a flow perfusion culture system that was modified according to Bancroft et al. 21) It utilizes the principle that fluid flow increases the deposition of a mineralized matrix during 3D perfusion culture of marrow stromal osteoblasts.
22) The cell-matrix constructs were cultured in the flow perfusion culture system for 7 d prior to surgery. They were rinsed twice with PBS, fixed in 2.5% glutaraldehyde in 0.1 M phosphate buffer for 2 h, and broken into two halves. The broken surfaces were sprinkled with aurum powder and processed by scanning electron microscopy (SEM) (S-3400N scanning electron microscope; Hitachi, Tokyo) to evaluate cell adhesion and cell penetration.
Implantation of cell-matrix constructs into radius defects in rabbits. The rabbits were divided into four experimental groups according to the type of graft performed (n ¼ 10 for each group): group 1 (control), defects were not treated; group 2, matrix scaffold alone; group 3, matrix scaffold with untreated MSCs; and group 4, matrix scaffold with MSCs expressing Cbfa1. To avoid immunological rejection in the latter two groups, the MSCs were isolated from homogeneous rabbits.
All operations were performed under general anesthesia by intravenous injection of a mixture of ketamine hydrochloride (40 mg/kg) and xylazine (10 mg/kg). After a longitudinal incision along the long axis under the knee joint of the forelimb the right radius was exposed, and segmental defects of the radius (1.2 cm length) were created using an electric router. The periosteum in the area of the bone defect was removed completely. Subsequently, various grafts were implanted without fixation into the defect sites. The left radius was used as a healthy control. The legs that had undergone surgery were immobilized for 7 d by casting in flexion. At 4 weeks, 8 weeks, and 12 weeks post surgery, two of the 10 rabbits were euthanized under anasthesia. Samples were fixed and used in subsequent paraffin sectioning and histological analysis. The four remaining animals in each group were euthanized under anesthesia at 12 weeks post surgery and the grafts were subjected to mechanical compression tests. All the animals were used according to the guidelines approved by the Council for Animal Protection of the Third Military Medical University. They were housed separately in temperature-controlled cages under hygienic conditions throughout the experiment and were fed a commercial diet and sterile tap water.
Histological, immunofluorescence and radiographic analysis. For histochemical analysis, hematoxylin and eosin (HE) and Masson's trichrome (MT) staining were performed to detect the cells and structure of the bone. The operative area within the right radius was removed from the euthanized rabbits and decalcified with EDTA solution (7%, pH 7.0). The decalcified bone tissues were fixed in 10% formalin overnight and embedded in paraffin after dehydration in 70% ethanol. The paraffin sections were fixed for 10 min with xylene and stained with HE (Sigma-Aldrich). For MT staining, fresh bone samples were fixed in freshly-made 4% paraformaldehyde in 0.1 M phosphate buffer (pH 7.4) at 4 C for 2 d, and then embedded in methyl methacrylate resin. Undecalcified sections (5 mm) were cut on a SM 2500E sliding microtome (Leica, Wetzlar, Germany). The percentage (%) of newly-formed bone within the defect was calculated using the computerized image analysis system SPOT version 4.1 (Diagnostic Instruments, Sterling Heights, MI). For immunofluorescence analysis, the sections were treated with an undiluted serum solution and incubated with a goat polyclonal anti-GFP antibody (Santa Cruz Biotechnology, Santa Cruz, CA) at 4 C overnight. Subsequently, the cells were incubated with fluorescein isothiocyanate (FITC)-conjugated mouse monoclonal anti-goat IgG (Sigma-Aldrich) for 30 min at room temperature. Immunofluorescent cells were observed and scanned with a CKX41-F32FL fluorescence microscope (Olympus, Tokyo). For radiographic analysis, each rabbit was positioned prone with the forelimbs rotated externally under intramuscular sedation. Serial radiographs of the radius were made at 4, 8, and 12 weeks post surgery. The X-ray findings were assessed in accordance with Yasko's criteria. 23) Biomechanical testing. Compression tests were not performed on group 1 because of bone nonunion. However, compression tests were performed on four scaffolds from each of four sample groups (n ¼ 4): groups 2, 3, and 4 are described above, and group 5 consisted of left radii that had not undergone surgery (n ¼ 12). Prior to testing of the implanted samples, as much soft tissue was trimmed away as could be removed without damaging the scaffolds. The ends of the samples were embedded in dental acrylic resin, and the two facets were kept parallel. All tests were conducted using an RGT-5A mechanics test system (Reger, Shenzhen, China) in the mode for cylinder-shaped specimens. A compression rate of 1.0 mm/min was applied. Load and displacement data were used to generate engineering stress-strain curves and to determine the compressive strength and stiffness of each sample. The breaking load was obtained from the slope of the curve. All data are expressed as the mean AE SEM. Statistical analyses between groups were performed by one-way analysis of variance (ANOVA) with a post-hoc t-test. P values were calculated, and significance was set at p < 0:05.
Results

Overexpression of Cbfa1 increased the osteogenic differentiation of MSCs in vitro
The MSCs that were used in this study displayed a long-term capability for self-renewal and showed consistent growth kinetics during expansion over a minimum of 10 passages in basal medium. These cells also showed an ability to differentiate into chondrogenic, osteogenic, and adipogenic lineages (data not shown), and demonstrated the characteristics of multipotent stem cells that have been described in multiple reports. One day after infection, GFP expression in the MSCs was detected by fluorescence microscopy (Fig. 1A and B) . Given that expression of the inserted gene perfectly parallels GFP expression in the Ad-Easy system, 16 ) the presence of the Cbfa1 gene was confirmed by GFP expression. To confirm Cbfa1 expression further, MSCs post-infection 7 d were harvested to western blot analysis. Compared with the uninfected MSCs, the Cbfa1 expression of MSCs infected with pAd-Cbfa1 adenovirus increased significantly (Fig. 1C) .
It is well established that MSCs have osteoblastic potential. Cbfa1 has consistently been found to be expressed in mammalian osteoblasts, but it is not known whether Cbfa1 affects the expression of osteoblast phenotypic markers in MSCs. To this end, total RNA was isolated from cells that had or had not been infected with the pAd-Cbfa1 adenovirus and subjected to semiquantitative RT-PCR analysis. As shown in Fig. 2 , normal MSCs (lanes 1 and 5) exhibited marginallydetectable levels of osteocalcin mRNA. Osteocalcin expression increased in untreated MSCs and MSCs treated with control adenovirus that were incubated in conditional medium (lanes 2 and 6 and lanes 3 and 7 respectively) as compared to MSCs incubated in ordinary medium. These levels increased dramatically on days 7 and 14 after infection with Cbfa1 adenovirus (lanes 4 and 8) . Similar results were observed for osteopontin mRNA. In contrast, expression of the type-I collagen gene in each culture did not change significantly with time, which indicates that Cbfa1 does not participate in the regulation of type-I collagen gene expression in MSCs. Overall, these results indicate that increased Cbfa1 expression in MSCs upregulates the expression of osteoblast phenotypic markers in vivo.
Expression of Cbfa1 mRNA was followed by an increase in alkaline phosphatase (ALP) activity and osteocalcin content, which correspond to markers of the early stage and the later stage osteoblast differentiation respectively. ALP activity in MSCs rose rapidly after the cells reached confluence, reached a peak on day 8, and then decreased in parallel with osteoblastic maturation. At all time points, ALP activity was significantly higher in the MSCs that had been infected with Cbfa1 adenovirus than in the control cells (Fig. 3A) . The osteocalcin content of the MSCs infected with the Cbfa1 adenovirus increased significantly at days 6, 8, and 10 after infection, as shown by radioimmunoassay (Fig. 3B) . However, Cbfa1 inhibited the expression of PPAR2 and MyoD, which are markers of adipogenesis and myogenesis respectively (data not shown). These results demonstrate that in MSCs, the expression of Cbfa1 significantly augments the expression of osteoblast markers at both the mRNA and the protein level.
MSCs spread and adhered adaptively in the cellmatrix constructs
As shown in Fig. 4A , the acellular bone extracellular matrix exhibited a macroporous microstructure. The seed cells were implanted into the scaffold after it had been pre-wetted with DMEM medium. After incubation for 1 d in an incubator, many cells were observed in the pores and periphery of the scaffold material by inverted microscope. These cells adhered to the matrix and could not be washed away by exchange of culture medium. SEM showed that the cells were in abundance in the center of the constructs day 7 in a flow perfusion culture system, and that they adhered to the surface of the scaffold, anchoring in the pores. As shown in Fig. 4B , the cells were spread flat and resembled fibroblasts on the surface of the matrix while variform MSCs filled the apertures of the constructs, which were interconnected with each other.
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Fig. 2. RT-PCR Analysis for the Osteoblast Phenotypic Marker Genes.
A, At 7 and 14 d after infection, significant differences were observed between the levels of osteocalcin and osteopontin mRNA in MSCs infected with pAd-Cbfa1 and those in the corresponding controls (p < 0:01). Similar results were obtained in two independent experiments. Lanes 1 and 5, uninfected MSCs in ordinary medium; lanes 2 and 6, uninfected MSCs in conditional medium; lanes 3 and 7, MSCs infected with control adenovirus; lanes 4 and 8, MSCs infected with pAd-Cbfa1 adenovirus. B, PCR bands were analyzed with Quantity One software. Changes in osteocalcin, osteopontin, and type-I collagen levels were quantified by densitometry.
Implantation of cell-matrix constructs into radius defects in vivo
At 12 weeks after implantation, all the artificial defects in group 4 showed radiographic evidence of healing, and the animals had fully recovered motor behavior. No complete unions were observed in the other groups (Fig. 5) . In group 4, cartilage, calcified cartilage, and osteoid appeared throughout the defect after 4 weeks. The implanted scaffolds degraded obviously and begun to dissolve into new bones. Many cells, such as chondrocytes and osteocytes, were found in the matrix apertures and bone lacuna. Abundant blood vessels surrounded the sites of implantation of the cellmatrix constructs. Some cells that expressed GFP were found on the matrix scaffolds at 4 weeks: the majority were on the outside of the acellular bone extracellular matrixes, but a few were found in the center (Fig. 6) . These results suggest that exogenous MSCs participated in bone remodeling. After 8 and 12 weeks, no GFPpositive cells were found at the above sites. At 8 weeks post surgery, the majority of the scaffolds had degraded and had been replaced by new bone and cartilage (Fig. 7D) . Cortical bone formed gradually from the margin to the area of the defect, where thicker cortical bone bridged across the defect. Segmental rebuilding of the marrow cavity also occurred. No GFP-positive cells were detected in the areas of restoration. At 12 weeks post surgery, the scaffolds had degraded completely. The cortical bone continued to rebuild and gradually became mature lamellar bone of normal thickness, shape, and alignment. New bone remolding was then complete and the marrow cavity was clear (Fig. 8D) .
Although the defects in groups 2 and 3 underwent a reparative process similar to those in group 4, the amount of new bone formation and degree of maturity in the former were significantly lower than in group 4 ( Fig. 7B, C; Fig. 8B, C) . In addition, no integrated marrow cavities were generated in the restored areas in groups 2 and 3. In the animals in group 3, islands of cartilage and scant bone formation were dispersed throughout the defect at 4 weeks post surgery, and some formation of marrow was evident after 12 weeks, but no rounded cavities were produced. Calcified cartilage and osteoid appeared throughout the defect, especially in the margin of the defect area.
The amount of bone formation differed significantly depending on the presence of a scaffold and/or MSCs. In group 2, where matrix alone was used, large amounts of new bone were created, even though much less bone was regenerated than in group 3 or 4. This suggests that acellular bone extracellular matrix alone can induce and direct bone formation in vivo. SEM observation showed A B Fig. 3 . ALP Activity and Osteocalcin Content at Different Time Points. A, ALP activity in MSCs infected by the Cbfa1 adenovirus rose rapidly after the cells reached confluence, reached a maximum value on day 8, and then decreased. The ALP activity in these cells increased significantly compared to the corresponding control groups. An asterisk indicates that the activity is statistically different from that for cells in normal medium or conditional medium or cells infected with the control adenovirus, after the same number of days in culture (p < 0:01). B, The osteocalcin content in MSCs infected with the Cbfa1 adenovirus significantly increased at days 6, 8, and 10 as compared to the controls (p < 0:01). Data shown are the mean AE SD for three separate experiments. A, Only a small amount of osseous tissue had grown from the bony margins to the area of the defect in group 1. B, In group 2, a large amount of bone callus had grown within the defect site and the matrix was not degraded completely. C, In group 3, some marrow formation was evident, but no rounded cavity was produced. D, New bone remolding was complete and the marrow cavity was clear in group 4. The arrows point to the defect sites.
that this type of scaffold exhibited a well-developed pore structure, and it appeared to provide a good environment for the growth of MSCs. The addition of MSCs to the scaffold increased the area of new bone significantly as compared with scaffold alone. The addition of MSCs that expressed Cbfa1 to the scaffold produced a significant further increase in the area of newly-formed bone as compared with scaffold alone or matrix scaffold with untreated MSCs. Conversely, in group 1, only a small amount of bone grew from the margin to the defect area, and no formation of cartilage or bone was observed in the central region of the defect at any time point ( Fig. 7A; Fig. 8A ). The defects were covered mainly by fibrillar connective tissue. These results suggest a direct functional link between cell-matrix constructs and the formation of new bone, especially in cells that express Cbfa1.
Results of radiographic analysis and compression tests
The distribution of radiographic scores for bone formation at each time point for each group is given in Table 2 . Significant differences in the amount of bone formation among the four groups were observed at all time points. Significantly more bone formation occurred in group 4 than in groups 1, 2, and 3 (p < 0:01). These data, in combination with the histological results, strongly suggest that the scaffold and Cbfa1-expressing cells together promote the formation of new bone. The results of the compression tests were used to generate stress-strain curves, and the breaking load was obtained from the slope of the curve. The compression breaking loads for groups 2, 3, 4, and 5 were 358:15 AE 13:65 N, 550:75 AE 38:15 N, 541:32 AE 23:17 N, and 624:25 AE 23:51 N respectively. There was no significant difference between groups 4 and 5 after 12 weeks (p > 0:05). In contrast, the breaking load for group 2 was significantly lower than that for groups 4 and 5 (p < 0:01) (Fig. 9) . 
Serial radiographs of the radius were made at 4, 8, and 12 weeks postoperatively. At various time points, the radiographic scores for bone formation for each group were evaluated. Significant differences were noted between group 4 and both group 2 and group 3 and group 4 (p < 0:01) at all intervals. Ã p < 0:01 compared with groups 2, 3, and 4.
Fig. 9. Mechanical Assessment of the Radius at 12 Weeks Post Surgery in Different Groups (n ¼ 4).
For the compression breaking load, no significant difference was observed among groups 3, 4, and 5 (p > 0:05). An asterisk indicates that the value is statistically different from that for the other groups (p < 0:01). 
Discussion
The repair of bone defects represents a major challenge for tissue engineering using stem cells. Bone marrow-derived MSCs facilitate bone repair when implanted locally, usually on an artificial matrix, such as hydroxyapatite/tricalcium phosphate or hydroxyapatite ceramic in the case of craniotomy or long-bone defects.
11) Quarto et al. 24) implanted a porous ceramic scaffold that had been loaded with MSCs into patients in whom the conventional use of MSCs was very difficult. They reported complete consolidation between implant and bone after 5-6 months. Peterson et al. 25) also found that a collagen-ceramic carrier seeded with MSCs derived from human adipose tissue that expressed BMP-2 could be engrafted into a large femoral defect in rats. The defect healed after 8 weeks. Kim et al. 26) loaded an acrylated hyaluronic acid scaffold with recombinant human BMP-2 protein and/or human MSCs and used this to regenerate a rat calvarial defect. Their results indicated that the hydrogels that contained both BMP-2 and MSCs resulted in the formation of mature bone. In the study described here, we combined acellular scaffolds with MSCs that had been modified genetically to express Cbfa1, and investigated their ability to participate in the regeneration of bone. The results of this study indicate that MSCs can play a crucial role in the repair of bone defects.
Approaches to increase the bone-forming capacity of MSCs are of great interest. Several growth factors, such as bone morphogenetic proteins (BMPs), insulin-like growth factors (IGFs), platelet-derived growth factor (PDGF), and fibroblast growth factors (FGFs) appear to improve bone healing. 27) In the work described here, we selected the key regulator of osteoblast differentiation, Cbfa1, which is also called runt-related transcription factor 2 (Runx2). Cbfa1 is the predominant transcriptional activator of osteoblast-associated genes, and is essential for osteoblast differentiation and bone formation. Although the ability of Cbfa1 to promote osteoblast differentiation has been elucidated, its effects on MSCs in vitro and in vivo have not been well characterized. The results of the present study indicate that the ALP activity and osteocalcin content of culture-expanded MSCs were enhanced significantly in response to Cbfa1. RT-PCR analysis showed that expression of the mRNA for osteoblastic markers could be detected in cultureexpanded MSCs, and also showed an increase in osteocalcin and osteopontin expression. These data indicate that the MSCs adopted an osteoblastic lineage in response to Cbfa1 in vitro.
In the animal model utilized, our data demonstrate that bone formation was significantly better, in terms of the amount of new bone formation and degree of maturity, when the scaffold was combined with MSCs that expressed Cbfa1 than in the other groups examined. Recently, Tu et al. 28) showed that reduced expression of Cbfa1 interferes with the process of bone wound healing, and that local application of Cbfa1 cDNA incorporated into a collagen matrix promotes bone tissue regeneration. Our data indicate that the same results can be achieved by the application of Cbfa1-modified MSCs. Combining our results with those of Kojima et al. 29) and Zheng et al., 30) the following roles of Cbfa1 in bone formation can be assumed: (i) as an osteoblastspecific transcription factor, Cbfa1 directly stimulates MSCs to form bone by activating the expression of a series of osteoblastic markers and inhibiting other differentiation pathways, such as adipogenesis and myogenesis; and (ii) it provides an appropriate environment for the differentiation of exogenous and autologous MSCs. Yamagiwa et al. 17) reported that bone tissue derived from human MSCs is found at the center of transplants, but not at the periphery. Bone tissue at the periphery and the bone marrow were identified as being of host origin. However, in our study, both autologously-derived bone and marrow cells and exogenously-derived MSCs were observed within the area of the defects. Although exogenously-derived MSCs were found throughout the regenerated bone, more were found in the peripheral portion than in the center of the transplants. We considered two possible factors might account for this difference in results. First, when the scaffold has been degraded and resorbed and the marrow cavity has reformed, the total number of cells in the center is far lower than in the periphery. Therefore, more seed cells are found in the periphery. Secondly, the scaffolds that we used were osteoconductive materials, which promote the localization of bone cells to bone-forming areas. These matrix scaffolds might act as a strong inducer of or an appropriate environment for the seed cells.
In group 4, new bone formation was detected both at the periphery and at the center of the transplants. In groups 1 and 2, less bone formation was observed at the periphery. These data suggest that bone regeneration was limited by the availability of recipient-derived bone-forming cells. They also imply that the seeded MSCs were required to construct the engineered bone. The long-term fate of the seed cells, including location, migration, and differentiation fate, remains to be investigated.
